Trial Profile
A randomized phase III trial comparing cisplatin with or without gemcitabine in patients with carcinoma of unknown primary and a predicted favorable prognosis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 06 Feb 2012 Results published in the European Journal of Cancer.
- 08 Feb 2006 New trial record.